![Andrew Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Parker
Chief Executive Officer at
ArisGen SA
Profile
Andrew Parker is currently the Chief Executive Officer of ArisGen SA and the Chief Executive Officer & Member-Supervisory Board of Step Pharma SAS. Previously, he worked as the General Partner & Scientific Director of Eclosion2 SA, Independent Director of GeNeuro SA (Switzerland), Scientific Director & General Partner of Eclosion2 & Cie Scpc, Principal at AstraZeneca PLC and Beerse Betonhandel, Vice President & Head-Exploratory Projects at Shire Plc, Chief Science Officer & Executive Vice President at Zealand Pharma A, Principal at Janssen Pharmaceutica NV, and Vice President-Pre Clinical Research at Opsona Therapeutics Ltd. Dr. Parker holds an MBA from Warwick Business School and a doctorate from The National Institute For Medical Research.
Andrew Parker active positions
| Companies | Position | Start |
|---|---|---|
ArisGen SA
 ArisGen SA Pharmaceuticals: MajorHealth Technology Manufactures novel products | Chief Executive Officer | - |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Chief Executive Officer | 05/09/2019 |
Former positions of Andrew Parker
| Companies | Position | End |
|---|---|---|
| ZEALAND PHARMA A/S | Chief Tech/Sci/R&D Officer | 31/08/2019 |
Eclosion2 SA
 Eclosion2 SA Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | - |
Eclosion2 & Cie Scpc | Corporate Officer/Principal | - |
| SHIRE | Corporate Officer/Principal | - |
| GENEURO SA | Director/Board Member | - |
Training of Andrew Parker
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Warwick Business School
 Warwick Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Beerse Betonhandel
 Beerse Betonhandel Regional BanksFinance Functions Related To Depository Banking Not Elsewhere Classified | Finance |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
The National Institute For Medical Research
 The National Institute For Medical Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Health Technology |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Provides financial services | Finance |
ArisGen SA
ArisGen SA Pharmaceuticals: MajorHealth Technology Manufactures novel products | Health Technology |
GeNeuro SA (Switzerland)
 GeNeuro SA (Switzerland) BiotechnologyHealth Technology Engages in the research and development of pharmaceutical products to treat neurological diseases | Health Technology |
Eclosion2 & Cie Scpc | |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
- Stock Market
- Insiders
- Andrew Parker
